No results displayed.
Inside "Interviews with Patients and Researchers":
@CancerQuest on Twitter:
Related to this page:
Was this page helpful?
|
Page 32 of 45 | <Previous : Next> Jump to Page:

Interview with Dr. Scott Lippman

Dr. Scott Lippman
Chair, Department of Thoracic/Head and Neck Medical Oncology
Division of Cancer Medicine
Professor, Department of Clinical Cancer Prevention and Population Sciences
The University of Texas M.D. Anderson Cancer Center


Dr. Lippman's research is directed at studying agents that might be able to prevent cancer or the recurrence of cancer that has been treated. In the interview, he discusses possible chemoprevention agents and the role of diet in chemoprevention.
Image of Dr. Scott Lippman

Questions and Answers

About Dr. Scott Lippman(Time: 6 sec)
Dr. Lippman's Area of Research(Time: 12 sec)
The Difference Between Chemoprevention and Chemotherapy(Time: 56 sec)
The Types of Drugs Used in Chemoprevention(Time: 43 sec)
Drugs That Can Prevent Recurrence in Cancer Patients(Time: 20 sec)
The Long-Term Side Effects of Cancer Drugs(Time: 42 sec)
Targeting Specific Cancer Pathways(Time: 1 min 57 sec)
Personalized Medicine and Targeted Therapies(Time:  5 min 02 sec)
The Benefits and Risks of Chemoprevention(Time: 3 min 44 sec)
The Role of Diets in Cancer Development(Time: 1 min 45 sec)
Page 32 of 45 | <Previous : Next>
Last Modified: 10/08/2010 Print Email Page Share
Copyright ©2012 Emory University. All rights reserved.
Direct questions and comments to cancerquest@emory.edu.
Disclaimer | Legal Policies | Contact 		Follow @CancerQuest on Twitter
CancerQuest Dictionary
Follow us on: